Back to Newsroom

StemCells, Inc. President and CEO Martin McGlynn to Present on a Regenerative Medicine Panel at the 2014 BIO International Convention

NEWARK, CA, June 23, 2014 (GLOBE NEWSWIRE) – StemCells, Inc. (Nasdaq:STEM) announced today that president and CEO Martin McGlynn will be a panelist at the 2014 BIO International Convention on June 25, 2014 at 4:15 pm PDT. Mr. McGlynn will participate in the panel discussion, “How International Collaboration is Accelerating the Field.” This panel will showcase examples of international collaboration that are producing results or initiating new approaches to cross-border research. Under Mr. McGlynn’s leadership, StemCells, Inc. launched a multi-national Phase I/II trial in spinal cord injury.

Click here to read more